FDA Demonizing Vape
FDA Demonizing Vape Industry with the Ban of Juul Products
June 23, 2022 11:51 ET | The Blinc Group
New York, June 23, 2022 (GLOBE NEWSWIRE) -- According to the Wall Street Journal, the Food and Drug Administration could order Juul to take its e-cigarettes off the U.S. market as early as this...
Achieve_Life_Sciences_Logo.jpg
Achieve Life Sciences Announces Participation at H.C. Wainwright 1st Annual Mental Health Conference
June 21, 2022 08:00 ET | Achieve Life Sciences
SEATTLE and VANCOUVER, British Columbia, June 21, 2022 (GLOBE NEWSWIRE) -- Achieve Life Sciences, Inc. (NASDAQ: ACHV), a late-stage clinical pharmaceutical company committed to the global...
Achieve_Life_Sciences_Logo.jpg
Achieve Life Sciences Awarded Grant from the National Institutes of Health to Conduct Phase 2 Trial of Cytisinicline in Nicotine e-cigarette Users
June 01, 2022 08:00 ET | Achieve Life Sciences
SEATTLE and VANCOUVER, British Columbia, June 01, 2022 (GLOBE NEWSWIRE) -- Achieve Life Sciences, Inc. (NASDAQ: ACHV), a late-stage clinical pharmaceutical company committed to the global...
Achieve_Life_Sciences_Logo.jpg
Achieve Life Sciences Announces Participation at LD Micro Invitational Conference
May 26, 2022 08:00 ET | Achieve Life Sciences
SEATTLE and VANCOUVER, British Columbia, May 26, 2022 (GLOBE NEWSWIRE) -- Achieve Life Sciences, Inc. (NASDAQ: ACHV), a clinical-stage pharmaceutical company committed to the global development and...
Achieve_Life_Sciences_Logo.jpg
Achieve Life Sciences Announces Participation at Best Ideas Virtual Investor Conference
May 13, 2022 08:00 ET | Achieve Life Sciences
SEATTLE and VANCOUVER, British Columbia, May 13, 2022 (GLOBE NEWSWIRE) -- Achieve Life Sciences, Inc. (NASDAQ: ACHV), a clinical-stage pharmaceutical company committed to the global development and...
Achieve_Life_Sciences_Logo.jpg
Achieve Reports Financial Results for First Quarter 2022 and Provides Corporate Update
May 12, 2022 16:00 ET | Achieve Life Sciences
SEATTLE and VANCOUVER, British Columbia, May 12, 2022 (GLOBE NEWSWIRE) -- Achieve Life Sciences, Inc. (Nasdaq: ACHV), a clinical-stage pharmaceutical company committed to the global development and...
22157.jpg
Global Dry Powder Inhalation Market Developments and Products Report 2022: Focus on Nicotine, Cannabinoids, Botanicals and Other Non-Medical Substances - Canceled, Under-Development, Clinical Trials
April 11, 2022 04:33 ET | Research and Markets
Dublin, April 11, 2022 (GLOBE NEWSWIRE) -- The "Dry Powder Inhalation Developments and Products In Scope of Nicotine, Cannabinoids, Botanicals and Other Non-Medical Substances Delivery, Designed By...
VPR Brands
VPR Brands Announces Favorable Settlement of Third Patent Infringement Case; Settlements Now Total Over $500,000
March 25, 2022 07:45 ET | VPR Brands LP
FORT LAUDERDALE, Fla., March 25, 2022 (GLOBE NEWSWIRE) -- via InvestorWire -- VPR Brands, LP (OTC: VPRB): VPR Brands is a market leader and pioneer in electronic cigarettes and vaporizers for...
Achieve_Life_Sciences_Logo.jpg
Achieve Life Sciences Announces Cytisinicline Presentation at Society for Research on Nicotine and Tobacco (SRNT) Annual Meeting
March 15, 2022 08:00 ET | Achieve Life Sciences
SEATTLE and VANCOUVER, British Columbia, March 15, 2022 (GLOBE NEWSWIRE) -- Achieve Life Sciences, Inc. (NASDAQ: ACHV), a clinical-stage pharmaceutical company committed to the global development...